Meet the Clinical Trial Team: The Principal Investigator
We continue our series by highlighting the principal investigator, who is responsible for the overall management of the trial.
Read More
PAST ARTICLES
2023
- Miami Breast Cancer Conference 2023
- Managing Other Health Conditions While Living with MBC
- Can I Participate in a MBC Clinical Trial if I Have Other Health Conditions?
- Meet the Clinical Trial Team: The Clinical Trial Coordinator
- What are Clinical Practice Guidelines and How are They Developed?
- Who are Clinical Trial Research Team Members?
- What to Know About MBC Treatment-Related Heart Problems
- What are Non-Treatment Trials and Why are They Important?
- Black Wo(Men) Speak Symposium 2022
- What is “Stable Disease” and How is it Monitored?
- Self-Advocacy: Your Voice in Your Cancer Care
- Clinical Trial Participation: The Patient’s Journey
- Metastatic Trial Search Featured in Clinical Trials Webinar
- Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
- I Found a Trial I’m Interested In. What’s Next?
- An Overview of Insurance and Clinical Trials
2022
- Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
- Why You Should Consider Repeat Biopsies
- Biomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
- Lobular Breast Cancer Metastasis: Highlighting the Researchers
- Breast Cancer Lung Metastasis: Highlighting the Experts
- How To Choose a Cancer Center
2020
SEARCH OUR SITE
for past articles or specific information.